GHK-Cu peptide claims: separating signal from influencer noise

What did @rootedfunctionalmedicine actually say?

Dr. Guthrie opened with a bold stat: "95% of people using peptides right now are doing it wrong." From there, the video pivoted quickly into a clinic pitch. She described peptides as "powerful signaling molecules" capable of supporting "metabolism, inflammation, healing, even nerve repair," warned against unsupervised use, and directed viewers to her telehealth service, GLOW Medical Peptides. The core argument was that peptide therapy without professional guidance is risky, and that her clinic offers a supervised, functional medicine alternative to the Wild West of online peptide buying. That framing is not entirely wrong. But the 95% figure has no citation behind it, and the transition from legitimate caution to promotional content happened fast enough to blur the line between education and advertising.

Does the science back this up?

On the biology, she's mostly right. Peptides are signaling molecules, and the ones she references in her hashtags, including GHK-Cu, BPC-157, and ipamorelin, do have research behind them. The issue is that "research exists" and "clinically validated for human use" are very different things.

GHK-Cu has shown wound healing and anti-inflammatory properties in cell and animal studies (Pickart et al., 2015, Journal of Aging Research). BPC-157 has demonstrated tissue repair effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design). Ipamorelin stimulates growth hormone release and has been studied in clinical contexts, though largely in older or deficient populations. None of these peptides have completed large-scale randomized controlled trials in healthy adults seeking optimization. The FDA has not approved most of them for general use, and several, including BPC-157, are not approved for human use at all in the U.S. That gap between promising preclinical data and validated human therapy is significant, and the video glosses over it entirely.

What did they get wrong (or right)?

Credit where it's due: the warning against "ordering peptides online, guessing dosages, stacking things they don't understand" is legitimate. Unregulated peptide markets are a real problem. Products sold online are frequently mislabeled, underdosed, or contaminated. A 2018 analysis found that a majority of unlicensed research peptide products failed purity standards (Brennan et al., 2018, Drug Testing and Analysis). The call for supervision is not wrong.

What she got wrong, or at least left dangerously vague, is the implied promise that peptides can reliably support "nerve repair" and metabolic outcomes when used through her clinic. That framing nudges right up against disease treatment claims without technically crossing the line. The "95%" statistic is presented as fact with zero sourcing. It's a rhetorical device, not data. Calling herself "the number one emerging functional medicine doctor in the United States of America of 2025" is an unverifiable marketing claim. Awards from functional medicine organizations are not peer-reviewed credentials.

What should you actually know?

Peptides are not a monolith. Some, like semaglutide (an approved GLP-1 peptide), have robust human trial data. Others, like BPC-157, are still in early-stage animal research with no approved human applications. Treating them as a single category, which this video essentially does, obscures genuinely important differences.

If you are considering peptide therapy, the questions that matter are: Is this peptide FDA-approved, or compounded? What phase of clinical evidence exists for your specific use case? Is your provider ordering labs and monitoring outcomes, or just prescribing based on a symptom questionnaire? Compounded peptides are not equivalent to approved drugs. They carry different quality, purity, and liability profiles. A telehealth clinic offering nationwide peptide prescriptions may be operating legally, but "legal" and "evidence-based" are not the same standard. Supervised use is better than unsupervised use. That part is true. But supervision does not substitute for clinical evidence.